Peptide Atlas · Peptide

Thymopentin (TP5)

In a double-blind trial in 100 patients with moderate to severe atopic dermatitis, six weeks of daily subcutaneous thymopentin reduced clinical severity, itching and redness more than placebo.

emerging

provisional
PubChem 451417
2 citations
0 discussions
0 followers
RKDVY
TP5
Timunox
thymopoietin (32-36)

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

No personal-experience post names it yet. When a member describes their own experience, PACIFIER reads it as such and it is listed here — labelled as experience, never as advice.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.